Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.09 USD | -4.39% | -1.80% | -18.05% |
May. 13 | HC Wainwright Adjusts Price Target on Co-Diagnostics to $2 From $2.50, Maintains Neutral Rating | MT |
May. 09 | Transcript : Co-Diagnostics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.05% | 34.07M | |
-19.42% | 18.12B | |
-41.90% | 2.87B | |
+19.36% | 1.9B | |
-1.05% | 1.65B | |
+33.96% | 1.34B | |
-16.83% | 957M | |
-21.96% | 896M | |
+7.07% | 841M | |
-26.98% | 612M |
- Stock Market
- Equities
- CODX Stock
- News Co-Diagnostics, Inc.
- Earnings Flash (CODX) CO-DIAGNOSTICS Reports Q3 Revenue $2.5M